Laurus Labs is trading 0.68% upper at Rs 827.15 as compared to its last closing price. Laurus Labs has been trading in the price range of 829.95 & 814.80. Laurus Labs has given 36.30% in this year & 3.53% in the last 5 days. Laurus Labs has TTM P/E ratio 92.17 as compared to the sector P/E of 25.87.There are 11 analysts who have initiated coverage on Laurus Labs. There are - analysts who have given it a strong buy rating & - analysts have given it a buy rating. - analysts have given the stock a sell rating.The company posted a net profit of 233.67 Crores in its last quarter.Listed peers of Laurus Labs include Glenmark Pharmaceuticals (-0.16%), Biocon (0.52%), Laurus Labs (0.68%).The Mutual Fund holding in Laurus Labs was at 6.88% in 31 Mar 2025. The MF holding has decreased from the last quarter. The FII holding in Laurus Labs was at 25.51% in 31 Mar 2025. The FII holding has decreased from the last quarter.
Updated on Jul 19, 2025, 12:09 AM UTC
|
|
|
|
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
---|---|---|---|---|---|---|---|---|
Glenmark Pharmaceuticals | Bullish | 2,223.05 | -0.16 | 62,734.65 | 37.95 | 5.69 | 0.14 | 7.90 |
Biocon | Bullish | 398.90 | 0.52 | 53,365.10 | 47.70 | 2.08 | 0.13 | 59.81 |
Laurus Labs | Bullish | 827.15 | 0.68 | 44,630.49 | 129.29 | 9.15 | 0.16 | 15.82 |
Suven Pharmaceuticals | Neutral | 1,071.50 | -1.97 | 40,005.70 | 96.40 | 15.12 | - | 10.36 |
Ipca Laboratories | Moderately Bullish | 1,472.00 | -0.15 | 37,297.86 | 40.79 | 5.17 | 0.28 | 8.55 |
Meeting Date | Purpose |
---|---|
2025-07-25 | Quarterly Results |
2025-04-24 | Audited Results & Interim Dividend |
2025-01-24 | Quarterly Results |
2024-10-24 | Quarterly Results & Interim Dividend |
2024-07-25 | Quarterly Results |
Laurus Labs is trading at 827.15 as on Fri Jul 18 2025 09:59:56. This is 0.68% upper as compared to its previous closing price of 821.55.
The market capitalization of Laurus Labs is 44630.49 Cr as on Fri Jul 18 2025 09:59:56.
The 52 wk high for Laurus Labs is 834.45 whereas the 52 wk low is 390.30
Laurus Labs can be analyzed on the following key metrics -
Laurus Labs reported a net profit of 358.32 Cr in 2025.
The Mutual Fund Shareholding was 6.88% at the end of 31 Mar 2025.